Compare VISTA PHARMA with KOPRAN. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs KOPRAN. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA KOPRAN. VISTA PHARMA/
KOPRAN.
 
P/E (TTM) x -81.2 17.3 - View Chart
P/BV x 1.5 3.8 39.3% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 VISTA PHARMA   KOPRAN.
EQUITY SHARE DATA
    VISTA PHARMA
Mar-20
KOPRAN.
Mar-21
VISTA PHARMA/
KOPRAN.
5-Yr Chart
Click to enlarge
High Rs21146 14.1%   
Low Rs522 20.8%   
Sales per share (Unadj.) Rs7.5113.7 6.6%  
Earnings per share (Unadj.) Rs-1.214.2 -8.5%  
Cash flow per share (Unadj.) Rs-0.816.6 -4.6%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs9.856.7 17.2%  
Shares outstanding (eoy) m30.3743.25 70.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.70.7 227.6%   
Avg P/E ratio x-10.45.9 -176.5%  
P/CF ratio (eoy) x-16.45.1 -324.4%  
Price / Book Value ratio x1.31.5 87.1%  
Dividend payout %010.5 0.0%   
Avg Mkt Cap Rs m3833,634 10.5%   
No. of employees `000NANA-   
Total wages/salary Rs m14372 3.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2284,918 4.6%  
Other income Rs m37182 20.6%   
Total revenues Rs m2655,100 5.2%   
Gross profit Rs m-48816 -5.9%  
Depreciation Rs m13102 13.2%   
Interest Rs m1562 24.7%   
Profit before tax Rs m-39833 -4.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3217 -1.2%   
Profit after tax Rs m-37616 -6.0%  
Gross profit margin %-21.116.6 -127.0%  
Effective tax rate %6.626.1 25.2%   
Net profit margin %-16.212.5 -129.0%  
BALANCE SHEET DATA
Current assets Rs m2122,769 7.6%   
Current liabilities Rs m1591,607 9.9%   
Net working cap to sales %23.123.6 97.8%  
Current ratio x1.31.7 77.2%  
Inventory Days Days25 33.4%  
Debtors Days Days165891 18.5%  
Net fixed assets Rs m2961,624 18.2%   
Share capital Rs m61433 14.0%   
"Free" reserves Rs m2362,018 11.7%   
Net worth Rs m2962,450 12.1%   
Long term debt Rs m55212 26.0%   
Total assets Rs m5074,394 11.5%  
Interest coverage x-1.614.4 -10.8%   
Debt to equity ratio x0.20.1 214.6%  
Sales to assets ratio x0.41.1 40.1%   
Return on assets %-4.215.4 -27.3%  
Return on equity %-12.425.1 -49.3%  
Return on capital %-6.833.6 -20.3%  
Exports to sales %18.540.5 45.7%   
Imports to sales %06.5 0.7%   
Exports (fob) Rs m421,990 2.1%   
Imports (cif) Rs mNA321 0.0%   
Fx inflow Rs m441,990 2.2%   
Fx outflow Rs m0374 0.0%   
Net fx Rs m441,617 2.7%   
CASH FLOW
From Operations Rs m8600 1.3%  
From Investments Rs m-17-244 7.1%  
From Financial Activity Rs m3-346 -0.8%  
Net Cashflow Rs m-610 -66.1%  

Share Holding

Indian Promoters % 6.2 43.8 14.2%  
Foreign collaborators % 20.7 0.0 -  
Indian inst/Mut Fund % 0.1 0.7 8.2%  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.1 56.2 130.1%  
Shareholders   10,700 38,195 28.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   KWALITY PHARMA  SOURCE NATURAL FOODS  CIAN HEALTHCARE  NATURAL CAPS  HESTER BIOSCIENCES  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VISTA PHARMA SHARE PRICE


Oct 14, 2021 (Close)

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

VISTA PHARMA 5-YR ANALYSIS

COMPARE VISTA PHARMA WITH

MARKET STATS